Formulation Applications of Hydroxypinacolone Retinoate Lotion: Technical Insights and Formula Design

Hydroxypinacolone Retinoate (BeriCos® HPR ) is an advanced retinoid active increasingly used in premium skincare formulations due to its anti-aging, skin-renewing, and tone-improving benefits. As a direct retinoic acid ester, Hydroxypinacolone Retinoate (BeriCos® HPR )  enables formulators to develop high-efficiency retinoid skincare with mild texture and excellent skin compatibility, perfectly suitable for anti-aging, brightening and daily skin maintenance lotions.



Application in Anti-Aging Lotion Formulations

Hydroxypinacolone Retinoate (BeriCos® HPR )  is corely applied in wrinkle improvement and skin rejuvenation lotion formulas. The conventional dosage of Hydroxypinacolone Retinoate (BeriCos® HPR )  in leave-on skincare is 0.05–0.3%, adjustable according to product positioning and regional cosmetic regulations.

For premium anti-aging lotions, Hydroxypinacolone Retinoate (BeriCos® HPR )  is usually compounded with multi-effect functional ingredients to realize comprehensive skin care: peptides, niacinamide, ceramides, hyaluronic acid, antioxidants, targeting fine lines, rough texture and skin sagging.

Classic HPR Anti-Aging Lotion Formula Proportion Range

  • Hydroxypinacolone Retinoate: 0.1–0.2% (active core ingredient)

  • Emollients: 5–15% (Caprylic/Capric Triglyceride, Squalane, Esters) – dissolve & deliver HPR

  • Emulsifiers: 2–5% – stabilize O/W lotion system

  • Humectants: 3–10% (Glycerin, Propanediol, Butylene Glycol) – long-lasting hydration

  • Barrier-support ingredients: 1–5% (Ceramides, Cholesterol, Fatty Acids) – relieve retinoid dryness

  • Antioxidants: 0.05–0.5% (Tocopherol) – prevent oxidation degradation

  • Preservatives: Added in accordance with industry standards & regulations


HPR Lotion Formulation Considerations

Hydroxypinacolone Retinoate (BeriCos® HPR )  isoil-soluble and extremely sensitive to oxidation, high temperature and light. To maximize active activity, standardized formulation and production control are required.

Standard Manufacturing Process

  1. Prepare oil phase: Mix emollients and emulsifiers, fully dissolve HPR in the oil phase.

  2. Prepare water phase: Dissolve humectants and all water-soluble ingredients evenly.

  3. Complete emulsification under constant temperature and stable stirring conditions.

  4. Cool down below 40°C before adding heat-sensitive active substances.

  5. Supplement antioxidants and auxiliary ingredients, adjust formula and fill.


Example HPR Lotion Formula Concept

Phase A – Water Phase

  • Deionized Water: q.s. to 100%

  • Glycerin: 5.0%

  • Propanediol: 3.0%

  • Niacinamide: 3.0%

Phase B – Oil Phase

  • Caprylic/Capric Triglyceride: 8.0%

  • Squalane: 5.0%

  • Emulsifier system: 3.5%

  • Cetyl Alcohol: 1.0%

Phase C – Cool Down Phase (≤40°C)

  • Hydroxypinacolone Retinoate: 0.15%

  • Tocopherol: 0.2%

  • Hyaluronic Acid: 0.1%

  • Preservative system: suitable level

This formula features balanced moisturizing texture, mild and non-irritating, perfectly fitting daily anti-aging lotion positioning.


Stability and Packaging Recommendations

Light and oxygen will cause Hydroxypinacolone Retinoate (BeriCos® HPR )  active degradation. Professional packaging selection is essential for shelf-life stability.

Optimal Packaging Options

  • Opaque airless pump bottles

  • UV-protective cosmetic containers

  • Aluminum sealed tubes

Formulators are recommended to conduct accelerated stability tests (temperature cycling, light exposure, long-term storage) to verify formula stability.



Future Applications & Conclusion

Hydroxypinacolone Retinoate (BeriCos® HPR )  lotion has broad market prospects in high-end skincare, especially suitable for sensitive skin anti-aging & barrier repair products. By optimizing Hydroxypinacolone Retinoate (BeriCos® HPR )  dosage, lipid delivery system and synergistic ingredients, brands can develop mild, safe and high-efficiency daily retinoid lotion.

As a versatile next-generation retinoid raw material, Hydroxypinacolone Retinoate (BeriCos® HPR )  empowers formulators to create premium skincare products that balance efficacy, mildness and sensory experience.


Hydroxypinacolone Retinoate manufacturer - Beri Pharma Co., Ltd


Beri Pharma Co., Ltd. - HPR Lotion


Formulation technical support available!

Elena@zhberi.com | +86 195 0079 6925

#BeautyScience #CosmeticFormulation #RAndD #BeriCosHPR

Comments

Post a Comment

Popular posts from this blog

NMPA Registed Pterostilbene - Beri Pharma Co., Ltd

Image
  NMPA Registed  Pterostilbene Pterostilbene is a dimethyl derivative of resveratrol, and its stability is significantly better than that of resveratrol, which is not included in the "Catalogue of Used Cosmetic Raw Materials (2021 Edition)", and is expected to become an upgraded alternative to resveratrol after being developed as a new cosmetic raw material, with high development value. 1. Whitening effect: inhibits tyrosinase activity 2. Anti-wrinkle and skin elasticity enhancement effect 3. Inhibits collagenase and elastase activities and enhances collagen secretion. 4. Protects against ultraviolet rays and enhances sun protection 5. Anti-inflammatory effect 6. Anti-glycation effects Beri Pharma Co., Ltd Beri Pharma Co., Ltd. - New NMPA registered Pterostilbene (google.com)
Read more

Hexylresorcinol Supplier - Beri Pharma - Hexyl Resorcinol (Cas 136-77-6)

Image
BeriCos® HR   Hexyl Resorcinol  Product name： Hexylresorcinol （HR） chemical Name: 4-Hexyl-1,3-benzenediol INCI: Hexylresorcinol Molecular weight: 194.27 Molecular formula: C12H18O2 CAS No.: 136-77-6 Application guidance Security Data & Laws and Regulations • Europe: Permitted in personal care products • USA：Permitted in personal care products • Japan：Permitted in personal care products • China：Permitted in personal care products Acute toxicity： • Rat Oral LD50：550mg/kg； • Mice transoral LD50:1040mg/kg； • Mouse abdominal cavity LD50：335mg/kg； • Mouse subcutaneous LDLo：750mg/kg； • Mouse pathway unknown LDLo：100mg/kg； • Guinea pig transoral LDLo：440mg/kg； Additional multi-dose data： • Oral TDLo of rats: 16250mg/kg/13W-I; • Mice transoral TDLo: 32500mg/kg/13W-I; • Tumorigenic data: Mice transoral TDLo:  64mg/kg/2Y-C; • Reproductive data: Subcutaneous exposure to TDLo 1 day before mating: 5mg/kg; • Mutagenicity data: Bacteria-E. coli DNA repair  system:...
Read more